AI Trade Positioning
Andrew Goldberg explains how investors should position their portfolios as earnings season gains momentum, focusing on the next leg of the AI trade.
2Market Analysis
Experts analyze Netflix results, AI investment strategies, biotech mergers, and regulatory shifts in South Korea.
This episode covers investor positioning for the AI trade, analysis of Netflix's earnings, biotech M&A trends, and regulatory changes in South Korea.
12345Prepared by GenPodAI-assisted and grounded in publisher-provided material
Andrew Goldberg explains how investors should position their portfolios as earnings season gains momentum, focusing on the next leg of the AI trade.
2Mark Mahaney analyzes Netflix's results, highlighting signals for growth, advertising performance, and implications for the broader media landscape.
3Michael Yee discusses the latest wave of biotech mergers and acquisitions, including Eli Lilly's move into psychedelics and where deal activity may accelerate.
4South Korea moves to ban new single-stock leveraged ETFs, impacting local market dynamics.
5Growing short interest in SpaceX suggests investors are debating whether early holders are hedging ahead of future share sales.
5Ask GenPod next
“What specific AI sectors are showing the strongest earnings momentum?”
“How does Netflix's advertising growth compare to its subscriber growth?”
“Which biotech companies are most likely to announce M&A deals next?”
Questions
Andrew Goldberg provides strategies for positioning as earnings season gathers momentum.
2Mark Mahaney analyzes the results to determine signals for growth and advertising.
3Michael Yee discusses the latest wave of biotech M&A and potential acceleration points.
4Investors debate whether early holders are hedging ahead of future share sales.
5Experts
Sources and disclosure
Primary material
GenPod used an AI-assisted workflow to organize publisher-provided show notes into a listening guide. It is not independent reporting or fact-checking; verify important claims against the source episode.
Read our methodologyReport a correctionHosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
GenPod publishes an independent listening guide. Rights in the original podcast audio, artwork, show notes, and trademarks belong to their respective owners.
If you own or represent the rights and believe material on this page is used without authorization, request review or removal. Include the original work, the material at issue, and your contact information.
Investors weigh results from Netflix, Alcoa and Intuitive Surgical.
Andrew Goldberg, Chief Global Strategist at Nomura Asset Management, explains how investors should position as earnings season gathers momentum.
Evercore’s Mark Mahaney analyzes Netflix’s results and what they signal for growth, advertising and the broader media landscape.
Our Annika Kim Constantino reports on Eli Lilly's move into psychedelics while Michael Yee of UBS discusses the latest wave of biotech M&A and where deal activity could accelerate next.
Plus, a look at South Korea's move to ban new single-stock leveraged ETFs and growing short interest in SpaceX as investors debate whether early holders are hedging ahead of future share sales.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Related listening guides